Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sven Borchmann

7PUBLICATIONS

13CO-AUTHORS

Predictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesCancer genetics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Mar 30, 2025

Correction: Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials.

P J Bröckelmann, H Müller, M Fuchs

|Mar 25, 2025

Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials.

P J Bröckelmann, H Müller, M Fuchs

|Oct 12, 2022

Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors.

Sven Borchmann, Carolin Selenz, Mia Lohmann

|Nov 14, 2021

Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).

Sarah Gillessen, Andreas Hüttmann, Vladan Vucinic

|Sep 14, 2021

9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.

Elena Gerhard-Hartmann, Helen Goergen, Paul J Bröckelmann

|Sep 09, 2021

Liquid biopsy in Hodgkin lymphoma - moving beyond the proof of principle.

Sven Borchmann

Pageof 2

Frequent Collaborators

3 joint publications

Dennis A Eichenauer

3 joint publications

Wolfram Klapper

3 joint publications

Bastian von Tresckow

2 joint publications

P J Bröckelmann

2 joint publications

J Ferdinandus

2 joint publications

H Tharmaseelan

2 joint publications

C Kobe

1 joint publications

Elena Gerhard-Hartmann

1 joint publications

Johanna Veldman

1 joint publications

Arjan Diepstra

Frequent Collaborators

3 joint publications

Dennis A Eichenauer

3 joint publications

Wolfram Klapper

3 joint publications

Bastian von Tresckow

2 joint publications

P J Bröckelmann

Top Related Videos

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on : Apr 12, 2024

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on : Oct 23, 2020

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

See more related videos

Top Related Videos

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on : Apr 12, 2024

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on : Oct 23, 2020

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

See more related videos